Introduction {#S1}
============

The NFκB family of dimeric transcription factors are known to control the development, maturation, and responses of the immune system comprising diverse cell types. Resting, unstimulated cells contain a latent pool of NFκB dimers in the cytosol that are stoichiometrically associated with their inhibitors, the IκBs ([@R1], [@R2]). NFκB transcription factors are produced by homo- or hetero- dimerization from a pool of five Rel homology domain-containing proteins (RelA, RelB, cRel, p50, and p52). The IκB family comprises several isoforms including the classical IκBα, IκBβ, IκBε proteins, and the IκBγ and IκBδ activities contained within the higher molecular weight IκBsome ([@R3]). Combinatorial dimerization and IκB-NFκB interactions are hallmarks of the IκB-NFκB signaling system.

The coordinated functions of IκB proteins in controlling the dynamics of NFκB activity have been studied systematically using a combined experimental and mathematical modeling approach. Specifically, mathematical modeling recapitulates key mechanisms, such as stimulus-responsive, IκB kinase (IKK)-dependent degradation of IκBs, release of nuclear NFκB DNA binding activity, as well as subsequent attenuation *via* the negative feedback regulators IκBα, IκBε, A20, and IκBδ ([@R4]). Interestingly, these studies did not identify a critical function for IκBβ, and IκBβ -deficient mice and cells show attenuated, not increased inflammatory responses ([@R5]).

In contrast, little recent progress has been reported on how NFκB dimers are generated. Early studies led to an appreciation that the NFκB transcription factor family consists of up to 15 possible dimers, and that different dimers are detectable in different cell types ([@R1]). In fact, the NFκB dimer repertoire changes dramatically during cell differentiation; for example B-cell lines with early lineage markers contain primarily RelA:p50, while those with later lineage markers contain primarily cRel:p50 dimers ([@R6]). In murine embryonic fibroblasts (MEFs), the RelA:p50 heterodimer and the RelA:RelA homodimer have been observed and shown to be responsible for the expression of distinct target genes ([@R7]). Indeed, despite its much lower abundance in fibroblasts, the RelA:RelA homodimer was shown to have non-redundant functions for a subset of NFκB target genes, with the specificity being mediated by κB-site DNA sequences as well as transcriptional co-activators ([@R8]). However, surprisingly little is known about the mechanisms that control the formation of these distinct NFκB dimers that are critical for mediating gene-specific expression control. Indeed, we presently lack a quantitative understanding of the most fundamental processes of monomer synthesis and subsequent dimer formation.

Here, we have employed mathematical modeling and experimental approaches iteratively to study the mechanisms that control the fibroblast-specific NFκB dimer repertoire. Guided by a model based on first principles of protein--protein interactions, and using *in vitro* biophysical interaction measurement, we found that we can only account for the *in vivo* observations of low affinity dimers when we considered additional mechanisms. Specifically, combined experimental and computational studies revealed that IκBβ functions as a positive regulator within the Rel-NFκB dimer generation module, and is essential for the formation of RelA:RelA homodimers. In contrast, IκBα is the key regulator of the dynamics of NFκB activity, not only of RelA:p50 but also of RelA:RelA. We conclude that the classical IκBs actually fall into two classes; whereas IκBα and -ε primarily function within the IκB-NFκB signaling module that is responsive to inflammatory stimuli, IκBβ primarily functions within the Rel-NFκB dimer generation module. The resulting model not only recapitulates experimental observations, but also explains the contrasting phenotypes of mice deficient for each of the classical IκBs.

Results {#S2}
=======

NFκB dimerization affinities and monomer competition {#S3}
----------------------------------------------------

To address the molecular basis for the generation of a MEF-specific repertoire of NFκB dimers within the so-called 'Rel-NFκB dimer generation module', we first considered the fundamental principles pertaining to the generation of homo- and hetero-dimers from the classical NFκB proteins p50 (50) and RelA (A), which are present in all differentiated human cells, and which show distinct gene-expression specificities ([@R7], [@R8]). Dimer abundance may be thought of as a function of monomer synthesis (*m~1~*, *m~2~*) and degradation (*m~−1~*, *m~−2~*), and combinatorial dimer association (*d~1~*, *d~2~*, *d~3~*) and dissociation (*d~−1~*, *d~−2~*, *d~−3~*) rate constants ([Figure 1A](#F1){ref-type="fig"}, [Supplementary Table 1, Supplementary Note 1](#SD1){ref-type="supplementary-material"}). As RNAseq data show very similar absolute abundances of the RelA and p50 encoding mRNAs in wild-type MEFs ([Supplementary Figure 1A](#SD1){ref-type="supplementary-material"}), the synthesis rates of the protein monomers are assumed to be equal in the model. As Rel proteins are obligate dimers, monomers are incompletely folded and more rapidly degraded *in vivo* than when dimerized (*dd~−1~*, *dd~−2~*, *dd~−3~*) ([@R9], [@R10]).

Dimerization affinities are key determinants of cellular homo- and hetero- dimer abundances. We simulated the abundance of RelA:RelA (A:A) and RelA:p50 (A:50) dimers as a function of those dimer affinities keeping the p50:p50 dimer affinity constant at 30 nM ([Figure 1B](#F1){ref-type="fig"}), 3 nM and 300 nM ([Supplementary Figure 1B](#SD1){ref-type="supplementary-material"}). Whereas p50:p50 dimerization affinity did not affect A:A or A:50 abundances over that range, the simulations do illustrate an interdependence between A:A and A:50 formation, whereby p50 competes for RelA monomers and may thus inhibit A:A generation. To test whether monomer competition occurs in cells, we compared *nfkb1^−/−^* (which lack p50) and wild type murine embryo fibroblasts (MEFs) and found an increase in the abundance of the A:A homodimers. These data support the concept that monomer competition is physiologically relevant and tends to diminish the abundances of weaker affinity dimers ([Figure 1C--E](#F1){ref-type="fig"}).

To parameterize the model, we next measured dimer affinities with biophysical techniques. Homodimer affinities were measured by analytical ultracentrifugation (AUC) using purified recombinant RelA and p50 dimerization domains ([Supplementary Figure 1C](#SD1){ref-type="supplementary-material"}). The heterodimer affinity was deduced from quantitative gel filtration experiments that provided the ratios of dimer abundances ([Supplementary Figure 1D--F](#SD1){ref-type="supplementary-material"}). We found remarkably disparate affinities: whereas the interactions by p50 proteins were found within the expected range (5--40 nM), the A:A homodimer affinity was in the µM range ([Figure 2A](#F2){ref-type="fig"}). Employing these rate constants in the kinetic model resulted in the prediction that the A:A homodimers would have exceedingly low abundance (\<4% of total RelA-containing dimers), due to a weak A:A affinity and the above-described monomer competition. However, testing this prediction experimentally, we found that A:A homodimers were readily detectable in cells amounting to about a quarter of TNF-inducible NFκB activities ([Figure 2B](#F2){ref-type="fig"}). Thus, the mismatch between model prediction and experimental results suggested that there might be additional mechanisms controlling dimer abundance, that are not included in this version of the kinetic model.

Interaction affinities between IκB isoforms and NFκB dimers {#S4}
-----------------------------------------------------------

Given that IκBs associate along a large dimerization interface ([@R11]), and NFκBs interacting with IκBs protect the latter from degradation ([@R12]--[@R14]), we considered the possibility that IκBs may stabilize RelA-containing NFκB dimers. (Classical IκBs do not interact with p50:p50 ([@R15]).) To test this idea, we extended the mathematical model by including IκB synthesis (*i~1~*) and degradation (*i~−1~*) and its interaction with A:A homodimers and A:50 heterodimers (*di~1~*, *di~−1~*, *di~2~*, *di~−2~*) ([Figure 3A](#F3){ref-type="fig"}, [Supplementary Table 2, Supplementary Note 2](#SD1){ref-type="supplementary-material"}). In the resulting model, NFκB dimer abundances are then also a function of IκB abundances and the interaction affinities between NFκB dimers and IκB proteins. These interactions are thought to be tight, ([@R12], [@R16], [@R17]) but systematic measurements using biophysical methods are hampered by the challenge of expressing and purifying full-length recombinant proteins that are not fully folded in the apo-form and have a tendency to aggregate.

To address this challenge, we developed an approach to derive *in vivo* IκB-NFκB affinities. The fact that IκBα, IκBβ, and IκBε protein abundances in MEFs deficient in classical NFκB dimers (*rela^−/−^crel^−/−^nfkb1^−/−^*) were much more reduced than their corresponding mRNA levels ([Figure 3B](#F3){ref-type="fig"}), indicated the degree to which the interaction with NFκB stabilized the half-life of the three classical IκBs as established by previous reports ([@R12], [@R14]). We reasoned that measurements of relative abundances of IκB proteins in mutant cells with alternate NFκB dimer repertoires could be used to infer *in vivo* IκB-NFκB dimer affinities.

To distinguish IκB interaction affinities for the A:50 and A:A dimers, we produced composite NFκB knockout MEFs (*relb^−/−^nfkb2^−/−^nfkb1^−/−^crel^−/−^*) in which RelA is the sole NFκB protein family member, and RelA-deficient MEFs, which do not contain A:A homodimers but contain the partially compensating cRel:p50 heterodimer in place of A:50 ([@R7], [@R18]) ([Supplementary Figure 2A, B](#SD1){ref-type="supplementary-material"}). Using these cells, the experimentally determined IκBα / IκBβ abundance ratios ([Figure 3C](#F3){ref-type="fig"}) constrained the acceptable ranges of IκB-NFκB affinities *via* model parameter fitting procedures ([Figure 4A](#F4){ref-type="fig"}). For example, in A:50-deficient cells, the IκBα abundance was reduced to 35 +/− 8% of that in wild type cells, constraining the IκBα-A:A and IκBα-A:50 affinity to a narrow band within the two dimensional parameter space (top left panel). In contrast, IκBβ abundance was hardly affected (76% +/− 24% of the wild type cells) and provided less constraint on the acceptable affinities of IκBβ -A:A and IκBβ -A:50 interactions based on the particular parameter landscape (top right panel). Similarly, IκBα and IκBβ abundance measurements in A:A-deficient cells provided additional constraints (bottom panels). The overlap of these acceptable ranges for each IκB in both NFκB knockout conditions determined not a single parameter set, but rather a narrower range of parameters that can account for all available experimental data.

As the NFκB dimer affinity and IκB abundance measurements are associated with experimental error, we sought to characterize the resulting uncertainty about the true IκB-NFκB affinities. To do so, we calculated a probability for each IκB abundance based on a two-fold variance around the mean of NFκB affinity measurements. Then we compared these values to the experimentally determined distributions (defined by mean and standard deviation) of IκB abundances. This allowed us to determine the likelihood that a given pair of IκB-A:A and IκB-A:50 affinities is true based on all available experimental data along with its associated uncertainty ([Figure 4B](#F4){ref-type="fig"}). This analysis allowed us to define the ranges of probable IκB-dimer affinities and it demonstrated that IκBβ was consistently predicted to have a clear preference for A:A over A:50 (\>100 fold). We chose seven parameter sets as representatives of the probable and improbable parameter spaces governing IκBα and IκBβ interactions ([Figure 4B](#F4){ref-type="fig"}, [Supplementary Table 5](#SD1){ref-type="supplementary-material"}) in order to ascertain their likelihood in further cell biological assays.

Testing the model of IκBβ controlling the RelA homodimer {#S5}
--------------------------------------------------------

Using the combination of probable and improbable parameter sets ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}) for IκB-NFκB dimer affinities within the experimentally determined ranges, we parameterized a mathematical model to account for the generation of distinct RelA dimers ([Figure 5A](#F5){ref-type="fig"}, [Supplementary Table 3, Supplementary Note 3](#SD1){ref-type="supplementary-material"}). We developed three predictions that depend on high IκBβ preference for the A:A homodimer and tested them experimentally. First, we used the model to calculate the basal abundance of RelA protein in cells containing only RelA (*relb^−/−^nfkb2^−/−^nfkb1^−/−^crel^−/−^*) under two regimes, probable and improbable affinity predictions ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}). We found that most probable affinity sets predicted a lower decrease (\~1.5--2 fold) in RelA protein levels than most improbable affinity sets ([Figure 5B](#F5){ref-type="fig"}). Indeed, immunoblot analysis showed only a small decrease (\~1.5 fold) in RelA protein ([Figure 5C](#F5){ref-type="fig"}).

Second, we used the model to simulate the steady state abundances of IκB-bound NFκB dimers in wild type cells; this resulted in the prediction that the majority of A:A homodimers are associated with IκBβ for the probable, but not the improbable affinity sets ([Figure 5D](#F5){ref-type="fig"}). Further, the majority of A:50 dimers were predicted to be associated with IκBα, but in some, the primary interaction partner was IκBβ ([Figure 5D](#F5){ref-type="fig"}). To test this prediction we prepared cytoplasmic extracts from unstimulated MEFs that contain latent IκB-NFκB complexes. The ionic detergent deoxycholate is known to disrupt IκB-NFκB interactions while leaving the dimer intact and capable of binding DNA ([@R19]), thereby revealing both latent RelA homo- and hetero- dimers ([Figure 5E](#F5){ref-type="fig"}, lane 2). By prior immuno-depleting IκBα or IκBβ, we found that IκBβ (\>50%) is indeed the primary interaction partner for the A:A homodimer (lane 6), whereas IκBα depletion left the A:A homodimer largely intact (lane 4). Additionally, we found that IκBα is the primary interaction partner (\>50%) for the A:50 heterodimer (lane 4), although some A:50 is bound to IκBβ as well (lane 6). Based on these data, we were able to narrow the probable parameter range by excluding parameter sets that did not satisfy the experimentally determined IκB-NFκB interactions ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}).

Finally, we asked whether IκBβ is in fact required for A:A homodimer generation. Computational simulations with the probable affinity sets predicted a dramatic decrease (\<20% of wild type) in A:A homodimer abundance in IκBβ -deficient but not IκBα-deficient cells ([Figure 5F](#F5){ref-type="fig"}). Improbable parameter affinity sets yielded variable amounts of A:A homodimer abundance in the three genotypes. Our experimental analysis supported the probable affinity sets' predictions: IκBβ -deficient cells showed a dramatic drop (\<2% of wild type) in the A:A homodimer abundance as revealed by deoxycholate treatment of cytoplasmic extracts, whereas IκBα-deficiency did not appear to alter the A:A homodimer repertoire (\>97% of wild type) ([Figure 5G](#F5){ref-type="fig"}). We then determined which of the parameter sets passed the above three tests. Remarkably, none of the improbable parameters allowed for correct predictions, while two parameter sets from the initially determined probable range did ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}). These three model-directed experimental studies thus support the notion that a high affinity for the A:A homodimer endows IκBβ with a stabilizing role in the abundance of the A:A homodimer. Interestingly, two NFκB target genes (*MIP-2* and *TNFα*), whose expression was found to be mediated by RelA:RelA homodimers, showed a marked reduction in IκBβ -deficient cells (particularly at late time points), whereas expression of RelA:p50 target genes was not reduced but elevated instead ([Supplementary Figure 3](#SD1){ref-type="supplementary-material"}).

IκBβ counters monomer competition to rescue RelA homodimer {#S6}
----------------------------------------------------------

Our work thus far has identified two systems properties that control the RelA:RelA abundance: monomer competition, and IκBβ -mediated stabilization. These mechanisms have opposing effects on RelA:RelA homodimer abundance, and so we examined their relationship to each other by simulating the effect of IκBβ -deficiency in the context of p50-containing or p50-deficient cells. In p50-deficient cells, compensation by p52 is observed but remains incomplete ([@R7]); in our simulations we account for that with a 30-fold reduction in p50 synthesis rates (qualitatively similar results were obtained with a range of synthesis rates) ([Figure 6A](#F6){ref-type="fig"}). We find that loss of IκBβ in p50-deficient cells result in lower A:A abundance, though the A:A homodimer remains detectable in contrast to results in p50-containing cells, in which A:A abundance was more IκBβ -dependent ([Figure 5F, G](#F5){ref-type="fig"}).

To test the validity of this model prediction, we generated p50/IκBβ -doubly-deficient MEFs and compared relative abundances of RelA homodimers as determined by EMSA ([Figure 1C](#F1){ref-type="fig"} and [6B](#F6){ref-type="fig"}). We found that in good agreement with the model predictions, IκBβ -deficiency results in a lower A:A abundance, but that detectable levels of A:A homodimer remained. Thus both our modeling and experimental results support the notion that IκBβ controls A:A abundance, and further suggest that IκBβ plays a key role in neutralizing the effect of monomer competition on the abundance of the low affinity A:A homodimer.

IκBα controls the dynamics of both RelA-containing dimers {#S7}
---------------------------------------------------------

The described mathematical model recapitulates the functions of the Rel-NFκB dimer generation module in generating the latent NFκB dimer repertoire in unstimulated fibroblasts. To study stimulus-induced dynamic regulation of the generation, activation and inactivation of RelA homo- and hetero- dimers, we connected this model with a well-tested model of the IκB-NFκB signaling module ([@R20]) to generate Model 4 ([Figure 7A](#F7){ref-type="fig"}, [Supplementary Figure 4A, Supplementary Table 4, Supplementary Table 5, Supplementary Table 6, Supplementary Note 4](#SD1){ref-type="supplementary-material"}).

A hallmark of NFκB signaling is negative feedback control mediated by IκBα that ensures post-induction repression of RelA:p50 activity following transient exposure to inflammatory cytokines ([@R20], [@R21]). To test whether the resulting model recapitulates the signaling dynamics of two NFκB dimers, we simulated TNF-induced signaling. Model simulations showed transient activation of both dimers in wild type cells with relative abundances that are supported by experimental measurements of both dimers. Post-induction repression was mediated by IκBα, as *iκbα^−/−^* MEFs showed sustained activity in both computational ([Figure 7B](#F7){ref-type="fig"}) and experimental studies ([Figure 7C](#F7){ref-type="fig"}), not only of the A:50 heterodimer, but also of the A:A homodimer. The sustained A:A homodimer activity in *iκbα^−/−^* MEFs is not due to an increase of IκBβ protein levels ([Supplementary Figure 4B](#SD1){ref-type="supplementary-material"}), but rather arises from the loss of negative feedback regulation of IκBα. While previous work has demonstrated the critical role of IκBα in the dynamic control of RelA:p50, our simulation and experimental results provide evidence that IκBα plays a role in the dynamic control of RelA:RelA activity as well.

We were curious how it could be possible that IκBα is the key dynamic regulator of A:A activity but does not contribute substantially to A:A homodimer generation. We investigated these two roles as a function of the affinity between IκBα and the A:A homodimer. We simulated both the basal abundance of the A:A homodimer and the duration of A:A homodimer activity above the threshold of a 50% of maximum activity ([Supplementary Figure 4C](#SD1){ref-type="supplementary-material"}) as a function IκBα-A:A homodimer affinities over a thousand-fold range ([Figure 7D](#F7){ref-type="fig"}). We found that lowering the IκBα-A:A affinity would prolong A:A homodimer activity following transient stimulation, but have little impact on A:A abundance; however, increasing the affinity would increase the basal abundance of the A:A homodimer. We thus conclude that the IκBα affinity for the A:A homodimer is tuned to be low enough that IκBα does not function within the Rel-NFκB dimer generation module, but high enough so that it functions within the IκB-NFκB signaling module to control the dynamics of A:A activity.

Discussion {#S8}
==========

The described work reveals a novel and specific function for IκBβ. IκBs are named "inhibitors of NFκB" because they are capable of inhibiting NFκB DNA binding activity in cell free *in vitro* assays ([@R19]), and IκBβ was identified in that same manner ([@R22]). However, we show here that *in vivo* IκBβ functions primarily as a positive regulator of NFκB dimer generation. Whereas the RelA:p50 dimers can readily form, owing to a high dimerization affinity, RelA:RelA homodimer formation requires the stabilizing influence of IκBβ. These distinct functions of IκBβ and other IκBs explain the phenotypes observed in knockout mice.

Previous studies of the IκB-NFκB signaling module revealed that negative feedback by IκBα, IκBε, and IκBδ shape the dynamics of NFκB activity in response to stimuli ([@R12], [@R20], [@R21], [@R23]--[@R25]). Indeed prolonged NFκB activity leads to a severe hyper-inflammatory phenotype in IκBα-deficient mice, and to hyper-proliferation in B-cells lacking IκBε ([@R26]) or IκBδ (Almaden et al, in press). However, IκBβ -deficient mice were recently reported to have hypo-inflammatory responses, reduced expression of TNF, and resistance to endotoxic shock and collagen-induced arthritis ([@R5], [@R27]). We show here that IκBβ -deficient fibroblasts lack one member of the NFκB dimer family, namely the homodimer of the potent activator RelA ([Figure 3](#F3){ref-type="fig"}). Similar resultant RelA:RelA and RelA:cRel-deficiency has been observed in *iκbβ^−/−^* macrophages ([@R5]).

Previously established mathematical models of the IκB-NFκB signaling module are unable to account for this phenotype. These models assume a constant amount of NFκB dimer as a given quantity, and calculate the control of its sub-cellular localization and DNA binding activity as a function of dynamically regulated IκB degradation and re-synthesis. Here, we have constructed a model for the Rel-NFκB dimer generation module and parameterized based on biophysical measurements of recombinant proteins and a series of iterative cycles of prediction and *in vivo* measurements. Our work reveals that IκBβ is critical for NFκB RelA:RelA homodimers in MEFs, whose spontaneous generation is challenged not only by poor intrinsic dimer affinities, but also by competition with the high affinity heterodimerization partner p50.

A key feature of IκBβ function is an unusually high affinity for RelA:RelA homodimers (3.2 pM). As recombinant IκBβ is not mono-dispersed in cell free systems, this model-aided interpretation of cellular measurements cannot be tested directly. While sub-nanomolar dissociation constants have previously been reported for other protein-protein interactions ([@R28]), it may be prudent to reconsider the simplifying assumption of the coarse grained model formulation in which IκBβ interacts only with the pre-formed dimer. Instead, IκBβ might be able to bind monomers sequentially ([Supplementary Figure 5A](#SD1){ref-type="supplementary-material"}), in which case IκBβ may be considered a *bona-fide* chaperone for RelA:RelA homodimer formation. Whereas the single step reaction scheme in the original model is +*A* ↔ *A*~2~ + *B* ↔ *A*~2~*B*, defining dissociation constants as $Kd_{1} = \frac{{\lbrack A\rbrack}^{2}}{\lbrack A_{2}\rbrack}$, *and* $Kd_{2} = \frac{\lbrack A_{2}\rbrack\lbrack B\rbrack}{\lbrack A_{2}B\rbrack}$, the two-step reaction scheme would be *A* + *B* ↔ *AB* + *A* ↔ *A*~2~*B*, defining dissociation constants $Kd_{3} = \frac{\lbrack A\rbrack\lbrack B\rbrack}{\lbrack AB\rbrack},Kd_{4} = \frac{\lbrack AB\rbrack\lbrack A\rbrack}{\lbrack A_{2}B\rbrack}$, and $Kd_{4} = \frac{Kd_{1}Kd_{2}}{Kd_{3}}$. Whereas *Kd~1~* and *Kd~2~* were determined to be 800 nM and 3.2 × 10^−3^ nM respectively, in the two-step model, *Kd~3~* is inversely proportional to *Kd~4~* ([Supplementary Figure 5B](#SD1){ref-type="supplementary-material"}). Thus a two-step model would yield interaction constants in the micro- and nano- molar ranges that are more commonly observed within bi-molecular interactions.

In addition to IκBβ 's described role within the Rel-NFκB dimer generation module, a hypo-phosphorylated IκBβ has also been shown to have nuclear functions in macrophages in protecting promoter-bound NFκB from IκBα-mediated negative feedback ([@R29]). Resistance to negative feedback may be imparted particularly to those NFκB dimers (e.g. A:A and RelA:cRel) that show high affinity for IκBβ ([@R5], [@R27]). As such, both the proposed nuclear function and the here-described chaperone function are a consequence of the high affinity for specific dimers revealed through our iterative experimental and computational study.

The parameterization of computational models is a recognized challenge of systems biology. Whereas strategies have been developed to parameterize mathematical synthesis and degradation expressions, as well as those describing enzymatic functions within cells, the interactions between proteins are rarely quantitatively addressed. *Ex vivo*, affinity and kinetic rate constants can be determined for the interaction of recombinant proteins, but the *in vivo* relevance of such constants is limited by the difficulties of producing recombinant full-length proteins with appropriate post-translational modifications. Here we exploited the fact the IκB abundance is a function of its interaction with NFκB ([@R12]) ([Figure 2B](#F2){ref-type="fig"}) and employed computational modeling in order to derive *in vivo* interaction affinities from immunoblot quantifications. Interestingly, it was previously observed that RelA deficiency results in IκBβ deficiency ([@R30], [@R31]), and such obligate interactions are not rare ([@R32], [@R33]), suggesting that our model parameterization strategy may be employed for other biological systems.

We described the Rel-NFκB dimer generation module and the IκB-NFκB signaling module as distinct but there are of course numerous interactions. At a minimum, we may consider that IκBβ, within the Rel-NFκB dimer generation module, functions as a 'licensing factor' for subsequent dynamic control by IκBα. The distinct functions by these structurally homologous proteins are based on both their specific protein-interaction constants, and on their distinct dynamic degradation and synthesis control. Indeed, the regulatory utility of such 'hand-off' or 'relay control' network motifs, based on kinetic differences between family members, may be a driver of the expansion of protein families.

Materials and Methods {#S9}
=====================

Computational modeling {#S10}
----------------------

Four computational models were constructed for this study. Models 1--3 ([Supplementary Notes 1--3](#SD1){ref-type="supplementary-material"}) address how NFκB dimers are generated from RelA and p50 NFκB monomers and how interactions with two IκB isoforms may affect the abundance of these dimers; model 4 addresses how nuclear localization of these NFκB dimers is induced and regulated following TNF-induced IKK activation.

Model 1 ([Figure 1A](#F1){ref-type="fig"}, [Supplementary Note 1](#SD1){ref-type="supplementary-material"}) contains RelA and p50, which form 3 NFκB dimers: RelA:A, RelA:p50, p50:p50. The rate constants for the parameters in these equations are found in [Supplemental Table 1](#SD1){ref-type="supplementary-material"}.

Model 2 ([Figure 3A](#F3){ref-type="fig"}, [Supplementary Note 2](#SD1){ref-type="supplementary-material"}) is based on model 1 above. A generic IκB can complex with RelA:A and RelA:p50. The p50:p50 dimer has not been demonstrated to bind to IκB, so that interaction is excluded from this model.) We assume no degradation of the IκB- NFκB complex or the NFκB dimer from the complex; the dimer may dissociate or IκB may degraded and release the NFκB dimer. The rate constants for the parameters in these equations are found in [Supplemental Table 2](#SD1){ref-type="supplementary-material"}.

Model 3 ([Figure 5A](#F5){ref-type="fig"}, [Supplementary Note 3](#SD1){ref-type="supplementary-material"}) is based on Model 2. IκBα/ε and IκBβ are the specific IκBs in the model, which can complex with RelA:A and RelA:p50. For simplicity, IκBα and IκBε are assumed to have the same molecular interaction characteristics and are treated as a single IκB species. The rate constants for the parameters in these equations are found in [Supplemental Table 3](#SD1){ref-type="supplementary-material"}. Parameterization of the model required exploration of the parameter space for IκB-NFκB affinities and determining the likelihood of each set of parameter values (see results [Figure 4B](#F4){ref-type="fig"}). Further parameterization involved additional experimental data ([Figure 5](#F5){ref-type="fig"}) in order to eliminate non-conforming parameter sets (see [Supplementary Table 5](#SD1){ref-type="supplementary-material"}).

Model 4 ([Figure 7A](#F7){ref-type="fig"}, [Supplementary Note 4](#SD1){ref-type="supplementary-material"}) appends previously published IκB-NFκB signaling models ([@R25], [@R34]) with the reactions that govern NFκB dimer generation and dimer-IκB interactions as described in model 3, but IκBα and IκBβ are explicitly enumerated. The complete new model contains 40 species and 110 reactions governed by 65 parameters ([Supplementary Table 4](#SD1){ref-type="supplementary-material"}). IκB-NFκB affinities were determined based on a series of experimental data that had to be satisfied (see [Supplementary Table 5](#SD1){ref-type="supplementary-material"}); parameterization included basal protein abundance measurements ([Supplemental Table 6](#SD1){ref-type="supplementary-material"})..

The model ODEs were solved numerically using MATLAB version R2013a (The MathWorks, Inc.) with subroutine *ode15s*, a variable order, multi-step solver. The system was allowed to equilibrate from starting conditions to a steady state, defined as showing no concentration changes greater than 1% over a period of 4000 minutes. Stimulus-induced perturbation from the steady state of Model 4 was accomplished by direct modulation of IKK activity via a numerical input curve representing TNF stimulation (adapted from Werner 2008). MATLAB code files are available upon request.

Deriving IκB-NFκB affinities {#S11}
----------------------------

Model 2 was used to calculate the IκB abundances in RelA:p50-deficient and RelA:RelA-deficient cells using NFκB dimerization affinities (determined by 31 sets of *d* parameters for homodimers and 31 sets of heterodimers) and IκB-NFκB interaction affinities (determined by 61 sets of *di* parameters for IκBα and 61 for IκBβ). NFκB dimerization affinities were measured with an assumed variance of two-fold, and so each IκB abundance in each cell could be associated with a probability. These were intersected with the experimentally determined distributions of IκB abundances (defined by mean and standard deviation), allowing us to determine the probability (based on available experimental data) that a specific set of the 3,575,881 possible parameter sets is correct. The probabilities for IκB-NFκB interaction affinities are shown in [Figure 4B](#F4){ref-type="fig"}. Specific sets of probable and improbable parameter combinations were further tested in [Figure 5](#F5){ref-type="fig"} against various experimentally determined outcomes to narrow down the most probably parameter sets.

Cell culture {#S12}
------------

Immortalized MEFs were prepared and cultured as previously described ([@R21], [@R23]). Briefly, cells were grown to confluence in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% bovine calf serum, 1% penicillin-streptomycin, and 1% L-Glutamine. Stimulations were performed using 1ng/mL TNF (Roche). The cell lines used were: wild-type (Hoffmann *et al*, 2002), *iκbβ^−/−^* ([@R23]), *iκbα^−/−^iκbε^−/−^*([@R21]), *iκbα^−/−^iκbβ^−/−^iκbε^−/−^*([@R12]), *rela^−/−^*([@R7]), *rela^−/−^crel^−/−^nfkb1^−/−^*([@R12]), *nfkb1^−/−^nfkb2^−/−^*([@R7]). *crel^−/−^relb^−/−^nfkb1^−/−^nfkb2^−/−^* knockouts were generated from E12.5--14.5 embryos and immortalized following the 3T3 protocol.

Biochemistry {#S13}
------------

EMSA ([@R21]), deoxycholate (DOC) + EMSA ([@R24]), EMSA supershift ([@R35]), wild-type + mutant oligo competition EMSA ([@R7]), immunodepletion, RNase Protection Assay ([@R23]), and immunoblotting ([@R21]) were performed as previously described. Briefly, for EMSA, nuclei were collected by hypotonic lysis and resuspended in 30µl NE buffer (250mM Tris pH7.8, 60mM KCl, 1mM EDTA, 1mM DTT, 1mM PMSF) and lysed by 3 freeze-thaw cycles. Nuclear lysates were cleared by 14000g centrifugation and adjusted to 1µg/µl total protein concentration. 2µg of total nuclear protein was incubated at room temperature for 15min. with 0.1pmoles of P32-labelled 30pb double-stranded oligonucleotide containing a consensus κB-site (AGCTTGCTACAA**GGGACTTTCC**GCTGTCTACTTT) in 3µl binding buffer (10mM Tri.Cl pH7.5, 50mM NaCl, 10% glycerol, 1% NP-40, 1mM EDTA, 0.1µg/µl polydIdC). Complexes were resolved on a non-denaturing gel and visualized using a Typhoon Scanner (GE Healthcare Life Sciences). For DOC sensitivity, 2µg of nuclear extract was treated with DOC to a final concentration of 0.8% for 30min and subsequently subjected to EMSA analysis. For supershifts, nuclear extracts were incubated with indicated antibody cocktails for 20 min on ice prior to probe incubation followed by resolution on non-denaturing gel. For wt-mutant competition EMSA, nuclear extracts were incubated with 100-fold molar excess of wt and mutant κB probes and resolved as before. For RNase Protection assay, total RNA was made from confluent serum-starved fibroblasts using Trizol-Reagent (Ambion by Life Technologies). RNase Protection Analysis was performed with 5µg RNA using Riboquant probe set mCK-5 (Pharmingen) according to manufacturers instructions. For whole cell western blots, cells were lysed within six-well plates using SDS--PAGE sample buffer, resolved on acrylamide gels, transferred to PVDF membranes and probed with specified antibodies.

IκBα (sc-371, 1:5,000), IκBβ (sc-946, 1:5,000 for immunoblot and sc-969, 1:20, for immunodepletion), RelA (sc-372, 1:5,000) antibodies were provided by Santa Cruz Biotechnology. p50 N-terminal antisera (1:10,000) was a generous gift from Nancy Rice.
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![Monomer competition reduces the abundance of the RelA homodimer\
A. A schematic of a simple model depicting the dimerization of NFκB RelA and p50 polypeptides. *m~1~* and *m~2~* are synthesis rate constants, *m~−1~* and *m~−2~* are degradation rate constants. *d~1~, d~2~*, and *d~3~* are dimer association rate constants, while *d~−1~, d~−2~,* and *d~−3~* are dimer dissociation rate constants. *dd~−1~*, *dd~−2~*, and *dd~−3~* are dimer degradation rate constants.\
B. Heat maps of protein abundances of A:A and A:50 dimers computationally simulated as a function of the dimer affinities (Kd). These were generated by the model schematized in (A).\
C. Electrophoretic mobility shift assays (EMSA) with nuclear extracts prepared from TNF-stimulated (30 min) wild type mouse embryonic fibroblasts (MEFs). The identity of the indicated DNA-protein complexes were confirmed using competition (comp.) with a 100-fold excess of unlabeled double stranded oligonucleotide that either contains the wild type (wt) or mutant (mt) κB site sequence. The RelA and p50 antibody (α--RelA and α-p50) are used in shift-ablation studies to confirm that the identity of the A:A-DNA and A:50-DNA complexes.\
D. EMSA with nuclear extracts prepared from TNF-stimulated (30 min) wild type and *nfkb1^−/−^* MEFs.\
E. Bar graph comparison of the abundances of A:A NFκB dimers wild type and *nfkb1^−/−^* relative to the wild type A:50 bands (100%) from panel (D).](nihms676392f1){#F1}

![Biophysical kinetic model underestimates the abundance of the RelA homodimer\
A. Summary table of dimer affinities as measured by analytical ultracentrifugation (AUC) and quantitative gel-filtration analysis of purified recombinant proteins ([Supplemental Figure 1B--E](#SD1){ref-type="supplementary-material"}). The A:A homodimer affinity is lower than those of p50-containing dimers.\
B. The bar graph is a quantitation from [Figure 1](#F1){ref-type="fig"} showing a comparison of model predicted (blue) and experimentally measured (red) relative abundances of A:A and A:50 dimers.](nihms676392f2){#F2}

![Differential interaction affinities for IκB and NFκB family members\
A. A model schematic of the Rel-NFκB dimer generation module. It depicts the dimerization of RelA and p50 NFκB polypeptides as in [Figure 1A](#F1){ref-type="fig"}, with the addition of a prototypical inhibitor of NFκB (IκB). *m~1~* and *m~2~* are RelA and p50 synthesis rate constants, *m~−1~* and *m~−2~* are RelA and p50 degradation rate constants. *d~1~, d~2~*, and *d~3~* are dimer association rate constants, while *d~−1~, d~−2~,* and *d~−3~* are A:A, A:p50, and p50:p50 dimer dissociation rate constants. *dd~−1~*, *dd~−2~*, and *dd~−3~* are A:A, A:p50, and p50:p50 dimer degradation rate constants. *i~1~* is the IκB synthesis rate constant, *i~−1~* is the IκB degradation rate constant. *di~1~* and di~*2*~ are the IκB-NFκB association rate constants. *di~−1~* and *di~−2~* are the IκB-NFκB dissociation rate constants. *did~1~* and *did~2~* are the IκB-NFκB degradation rate constants of IκB to release NFκB.\
B. Immunoblot (left panel) of whole cell extracts of wild type MEFs and MEFs deficient in canonical NFκB genes (RelA, cRel, and p50) using antibodies against the indicated proteins (IκBα, IκBβ, and IκBε). RNAse protection assay (RPA, right panel) of previous extracts to measure transcript levels of the indicated genes (IκBα, IκBβ, IκBε, and L32). Immunoblot and RPA data are representative of more than three independent experiments that consistently show a deep reduction IκB protein levels without a corresponding reduction in transcript levels.\
C. Immunoblot of indicated IκBs in indicated NFκB dimer compound knockout MEFs as compared to wild type MEFs, with the indicated NFκB dimers below. The blot is a representative of three independent experiments that consistently showed that presence of RelA is required and sufficient for the detection of IκBβ protein. Quantitation of this data is shown as bar graphs in [Figure 4A](#F4){ref-type="fig"}.](nihms676392f3){#F3}

![Deriving probable IκB-NFκB interaction affinities from experimental data\
A. Surface plots of indicated IκB abundances (−α or −β) in cells deficient for the indicated NFκB dimer (RelA:p50 heterodimer-deficient, top; RelA:RelA homodimer-deficient, bottom) over the indicated ranges of IκB-NFκB affinities, as predicted by the model schematized in [Figure 3A](#F3){ref-type="fig"}. Middle, bar graphs of the experimentally IκB abundances in the indicated NFκB dimer-deficient cells relative to WT. (A representative data figure is shown in [Figure 3C](#F3){ref-type="fig"}.) Experimentally determined abundances constrained the range of allowable IκB-NFκB affinities in the surface plots, indicated by shadows on the xy-plane.\
B. Heat maps of probable IκB-NFκB affinities. Probabilities (indicated in the color scale) were calculated using the distribution experimental measurements, defined by mean and standard deviation ([Figure 2A](#F2){ref-type="fig"}, [Figure 3C](#F3){ref-type="fig"}, Figure 4A); they describe the relative likelihood that an indicate parameter set if correct based on available experimental data. The most probable IκB-NFκB affinities are in red, while the least probable affinities are in dark blue. Selected probable and improbable parameter values are indicated (white letters and numbers, listed in [Supplementary Table 5](#SD1){ref-type="supplementary-material"}), and were used for model predictions in [Figure 5](#F5){ref-type="fig"}.](nihms676392f4){#F4}

![Iterative testing and refinement of the IκBβ -RelA homodimer preference model\
A. A model schematic of the Rel-NFκB dimer generation module, as in [Figure 3A](#F3){ref-type="fig"} but with two IκBs, IκBα and IκBβ, necessitating *i~1~* and *i~2~* synthesis rate constants, *i~−1~* and *i~−2~* degradation rate constants, *di~1~,di~2~*, *di~3~*, and *di~4~* IκB-NFκB association rate constants. *di~−1~*, *di~−2~, di~−3~,* and *di~−4~* IκB-NFκB dissociation rate constants, and *did~1~*, *did~2~, did~3~,* and *did~4~* IκB-NFκB degradation rate constants of IκB to release NFκB.\
B. Computational prediction of RelA protein abundance in A:50-deficient cells (relative to wild type cells), using probable (red) and improbable (blue) affinities shown in [Figure 4B](#F4){ref-type="fig"} and listed in [Supplementary Table 5](#SD1){ref-type="supplementary-material"}.\
C. Immunoblot against RelA of whole cell extracts from RelA-deficient, wild type, and RelA-only MEFs. The right panel shows the quantitation of three independent experiments. These consistently showed values of \> 0.5.\
D. Computational predictions of the abundances of NFκB dimers RelA:RelA (left) and RelA:p50 (right) bound to either IκBα or IκBβ as indicated. These calculations used probable (red) and improbable affinities (blue) as in panel B.\
E. Electrophoretic mobility shift assay of deoxycholate (DOC)-treated cytoplasmic extracts (which results in the separation of NFκB dimers from IκBs) to quantitate IκB-bound NFκB dimer abundance. Prior immunodepletion of the extracts with antibodies against IκBα or IκBβ allows quantitation of NFκB bound to the remaining IκB isoform. Data shown is representative of three independent experiments, and the right panel shows the corresponding quantitation.\
F. Computational predictions of the basal abundances of the RelA:RelA homodimer in wild type, IκBβ -deficient, and IκBα-deficient MEFs using probable (red) and improbable (blue) affinities as in panel B.\
G. Electrophoretic mobility shift assays (left panel) of DOC-treated cytoplasmic extracts of wild type, IκBβ -deficient, and IκBα/ε-deficient MEFs. Shown is a representative result of three independent experiments, and the right panel shows the corresponding quantitation.](nihms676392f5){#F5}

![IκBβ is important in RelA homodimer formation\
A. Bar graph depicting the simulation results of NFκB dimer abundances in wild type, IκBβ -deficient, p50-deficient, and IκBβ /p50 doubly deficient MEFs. Compensation by p52 in p50-deficient cells was simulated by allowing for synthesis of a p50-like molecular species.\
B. Electrophoretic shift mobility assay of nuclear extracts prepared from p50- deficient and p50/IκBβ -deficient MEFs treated with TNF at 10 and 30 minutes. In the absence of p50-mediated monomer competition, the RelA:RelA homodimer is highly abundant, even in the absence of IκBβ. Data shown is representative of three independent experiments.](nihms676392f6){#F6}

![While IκBβ regulates NFκB/RelA homodimer generation, IκBα regulates its signaling\
A. A schematic showing the linking of the Rel-NFκB dimer generation module and the IκB-NFκB signaling module ([@R20]) to simulate stimulus-induced activation of multiple NFκB dimers. IκBα, IκBβ, and IκBε interact with A:A and A:50 dimers as described in [Figure 5A](#F5){ref-type="fig"}. A detailed model schematic is shown in [Supplemental Figure 5A](#SD1){ref-type="supplementary-material"}.\
B. Computational time course simulations of TNF-stimulated nuclear DNA binding activity of the indicated NFκB dimers A:50 (left, solid lines) and A:A (right, dashed lines) in wild type (blue) and IκBα-deficient (red) MEFs. Both dimer activities exhibit post-induction repression mediated by IκBα.\
C. Electrophoretic mobility shift assays (top panels) of nuclear extracts of wild-type and IκBα-deficient MEFs prepared from TNF-stimulated cells at 30, 60 and 90 minutes. Quantitation (bottom panels) of the A:50 (solid lines) A:A and A:50 (dashed lines) NFκB dimers show prolonged activation in IκBα deficient (right, red) as compared to wild-type (left, blue) MEFs. Shown is a representative of at least three independent experiments.\
D. Computational simulations of A:A abundance (green) and duration of TNF-induced A:A activity (purple) as a function of the interaction affinity between IκBα and the A:A. These simulations were performed with the integrated model described in (A), and they show that a lower Kd would allow IκBα to contribute to A:A generation, while a higher Kd would reduce IκBα's ability to terminate TNF-induced A:A activity.](nihms676392f7){#F7}
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